NCT07681323Recruiting
Timing of ctDNA Testing in Advanced Breast Cancer
Timing of ctDNA Testing in Advanced Breast Cancer: Impact on Prognosis and Treatment Strategies - A Prospective Observational Study (TIMING)
Source: ClinicalTrials.gov · Last updated 15 Sept 2026
Brief summary (registry, in English)
This multicenter, prospective observational cohort study aims to investigate the impact of circulating tumor DNA (ctDNA) level and key actionable gene mutation status on prognosis and treatment response in patients with advanced breast cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 26 Jun 2026
- Start date
- 8 Jul 2026
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Geneplus-Beijing Co. Ltd.
- Diseases
- Metastatic breast cancer
- NCT number
- NCT07681323
What you commit to
- Study type: Observational
- Planned participants: 400
- From 8 Jul 2026 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- The subject has not signed the informed consent form.
- Pregnant or breastfeeding women.
- Other situations deemed by the investigator as unsuitable for inclusion in the study.
Who the study is looking for
- Histologically confirmed advanced breast cancer
- Age ≥18 years
- Expected survival \>3 months
- Willing to undergo ctDNA testing and sign informed consent form
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.